The application value of inhaled corticosteroid combined with formoterol in asthma maintenance and reliever therapy
10.3760/cma.j.issn.1673-4408.2025.01.004
- VernacularTitle:吸入性糖皮质激素联合福莫特罗在哮喘维持和缓解治疗中的应用价值
- Author:
Jiao WANG
1
;
Xueyan WANG
Author Information
1. 天津医科大学第二医院儿科 300202
- Keywords:
Asthma;
ICS-formoterol;
Maintenance and reliever therapy;
Anti-inflammatory reliever
- From:
International Journal of Pediatrics
2025;52(1):17-21
- CountryChina
- Language:Chinese
-
Abstract:
Asthma is one of the most common chronic respiratory diseases.Inhaled corticosteroid（ICS）are the first line of asthma maintenance therapy.ICS maintenance therapy combined with short-acting beta-2 agonist（SABA）reliever therapy has been a common treatment in the past few decades.However，there are some problems such as poor patient compliance.In recent years，the Global Initiative for Asthma（GINA）has suggested that low-dose ICS-formoterol is preferred as a reliever therapy to help improve patient compliance and reduce the risk of exacerbation after an acute attack of asthma.This article summarizes the application value of ICS-formoterol in the treatment of asthma maintenance and reliever.
